News | Cath Lab | April 18, 2018

SCAI Announces Global Lecture Series for 2018 Scientific Sessions

Topics include the contributions of female interventionists, the importance of evidence-based science and the future of interventional cardiology

SCAI Announces Global Lecture Series for 2018 Scientific Sessions

April 18, 2018 — Many of the world’s leading interventional cardiologists and cardiovascular professionals will convene in San Diego, Calif., April 25-28, 2018, for the Society for Cardiovascular Angiography and Interventions (SCAI) 2018 Scientific Sessions. The annual event will attract nearly 2,000 leading interventionalists and cardiovascular professionals from across the globe for a dynamic four-day program featuring 12 live cases, late-breaking clinical science, case reviews, abstract presentations and interactive workshops.

A key component of this international meeting is the SCAI Lecture Series, which will feature renowned speakers who will challenge current thinking in the field and inspire the next generation of interventional cardiologists.

Scheduled lectures include:

Hildner Lecture: “A Pivotal Time for Interventional Cardiology”

Anthony N. DeMaria, M.D.

Since its inception by Andreas Gruentzig, interventional cardiology has been a wonder of innovation and conveyed enormous benefits to patients with coronary and structural heart disease. However, several recent trials have raised questions regarding the prognostic and even symptomatic benefit of coronary interventions in patients with stable angina. As technological advances continue to be pursued, it will be essential to take stock of pathophysiology, and to conduct rigorous studies to define those individuals with stable angina most likely to benefit from an intervention. Additionally, therapies for structural lesions are expanding dramatically, along with approaches to address mitral and tricuspid valve disorders. DeMaria will discuss how new research developments and structural innovations will change the face of interventional cardiology.

 

Founder’s Lecture: “Ongoing Scrutiny: Evidence-Based Science in Interventional Cardiology”

Roxanna Mehran, M.D., MSCAI

Interventional cardiology, as a medical specialty, has faced intense scrutiny from its origin that continues through present day. From early studies in angioplasty and balloons to more recent trials involving 20,000 patients at a time, practitioners face extensive professional and public scrutiny and a demand for ever-increasing precision in how they treat their patients. Approval processes for devices and medications follow clinical trials, but it is the practitioners’ post-market surveillance that defines their clinical practices and treatment strategies. Mehran will take attendees on a 40-year journey of medical scrutiny with a unique presentation that promises a few twists and turns — and even some surprises.

 

Mullins Lecture: “Celebrating Women Who Paved the Way to Pediatric Cardiology Today”

Jacqueline Kreutzer, M.D., FSCAI

The field of pediatric cardiology has evolved with tremendous contributions by female physicians who played an integral role in the evolution of the specialty. Kreutzer will review and highlight the pivotal roles played by female physicians, and the innovations and contributions they have made to the field of pediatric cardiology.

For more information: www.scai.org

 


Related Content

News | Cath Lab

December 20, 2023 — Jason R. McCarthy, Ph.D., associate professor of biomedical research and translational medicine and ...

Home December 20, 2023
Home
News | Cath Lab

October 26, 2023 — Royal Philips, a global leader in health technology, announced the latest results demonstrating the ...

Home October 26, 2023
Home
News | Cath Lab

October 25, 2023 — Shockwave Medical, Inc., a pioneer in the development and commercialization of transformational ...

Home October 25, 2023
Home
News | Cath Lab

October 20, 2023 — Over the coming days, Philips will be presenting its latest solutions in cardiology and new late ...

Home October 20, 2023
Home
News | Cath Lab

October 16, 2023 — GE HealthCare (Nasdaq: GEHC) announced US FDA 510(k) clearance of Allia IGS Pulse - the latest ...

Home October 16, 2023
Home
News | Cath Lab

October 16, 2023 — Shimadzu Medical Systems USA, a subsidiary of Shimadzu Corporation, announced the first U.S ...

Home October 16, 2023
Home
News | Cath Lab

September 13, 2023 — A diagnostic test, first offered in the United States at University Hospitals (UH) Harrington Heart ...

Home September 13, 2023
Home
News | Cath Lab

August 2, 2023 — Teleflex Incorporated, a leading global provider of medical technologies, announced the U.S Food and ...

Home August 02, 2023
Home
News | Cath Lab

July 13, 2023 — Mount Sinai Queens announced the opening of a new cardiac catheterization lab that will provide rapid ...

Home July 13, 2023
Home
News | Cath Lab

June 21, 2023 — Royal Philips, a global leader in health technology, announced it has teamed up with BIOTRONIK (Lake ...

Home June 21, 2023
Home
Subscribe Now